Sec. 8.5. As used in this chapter, “normal distribution chain of custody” means the route that a legend drug travels:

(1) from a manufacturer to a wholesale drug distributor, to a pharmacy, and to a patient or a patient’s agent;

Ask a business law question, get an answer ASAP!
Thousands of highly rated, verified business lawyers.
Click here to chat with a lawyer about your rights.

Terms Used In Indiana Code 25-26-14-8.5

  • board: refers to the Indiana board of pharmacy established under IC 25-26-13-3. See Indiana Code 25-26-14-4
  • chain drug warehouse: means a permanent physical location for drugs or devices, or both, that:

    Indiana Code 25-26-14-3.7

  • legend drug: has the meaning set forth in IC 16-18-2-199. See Indiana Code 25-26-14-7
  • manufacturer: means a person who is engaged in manufacturing, preparing, propagating, compounding, processing, packaging, repackaging, or labeling of a legend drug. See Indiana Code 25-26-14-8
  • third party logistics provider: means an entity that:

    Indiana Code 25-26-14-10.5

  • wholesale drug distributor: means a person engaged in wholesale distribution of legend drugs, including:

    Indiana Code 25-26-14-12

(2) from a manufacturer to a wholesale drug distributor, to a chain drug warehouse, to a pharmacy affiliated with the chain drug warehouse, and to a patient or a patient’s agent;

(3) from a manufacturer to a chain drug warehouse, to a pharmacy affiliated with the chain drug warehouse, and to a patient or a patient’s agent;

(4) from a manufacturer to a third party logistics provider, to a wholesale drug distributor, to a pharmacy, and to a patient or a patient’s agent;

(5) from a manufacturer to a third party logistics provider, to a wholesale drug distributor, to a chain drug warehouse, to a pharmacy affiliated with the chain drug warehouse, and to a patient or a patient’s agent;

(6) from a manufacturer to a third party logistics provider, to a chain drug warehouse, to a pharmacy affiliated with the chain drug warehouse, and to a patient or a patient’s agent; or

(7) as prescribed by rules adopted by the board.

As added by P.L.212-2005, SEC.39.